Zemuron (Organon USA Inc.)
Welcome to the PulseAid listing for the Zemuron drug offered from Organon USA Inc.. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Organon USA Inc. |
NON-PROPRIETARY NAME: | rocuronium bromide |
SUBSTANCE NAME: | ROCURONIUM BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1994-03-17 |
END MARKETING DATE: | 0000-00-00 |
Zemuron HUMAN PRESCRIPTION DRUG Details:
Item Description | Zemuron from Organon USA Inc. |
LABELER NAME: | Organon USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 1994-03-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0052-0450_165d8174-d588-461d-8a18-8ac0988cbbb0 |
PRODUCT NDC: | 0052-0450 |
APPLICATION NUMBER: | NDA020214 |
Other ROCURONIUM BROMIDE Pharmaceutical Manufacturers / Labelers: